A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...] …
Category: Pharma Industry
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...] …
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...] …
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...] …
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...] …
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...] …
An influential drug industry trade group on Friday sued Utah over its 340B contract pharmacy access law, marking the third [...] …